// App-Quantinova.ai

13908 : Tailored Antiplatelet Therapy to Improve Prognosis in Patients Exhibiting Clopidogrel Low-response Prior to Percutaneous Coronary Intervention

Researchers

Presenter

  • Par I. Johansson

Principal Investigators

  • Peter Clemmensen

  • Lene Holmvang

  • Maria D. Radu

  • Abbas Qayyum

  • Jacob Loenborg

  • Henning Kelbaek

  • Steffen Helqvist

  • Erik Joergensen

  • Kari Saunamaki

  • Thomas Engstroem

Medical Centers

  • N/A

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Acute Coronary Syndromes

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved